Zobrazeno 1 - 10
of 48
pro vyhledávání: '"Haydn T. Kissick"'
Publikováno v:
Frontiers in Pharmacology, Vol 7 (2016)
Advances in molecular pathology have changed the landscape of oncology. The ability to interrogate tissue samples for oncogene amplification, driver mutations, and other molecular alterations provides clinicians with an enormous level of detail about
Externí odkaz:
https://doaj.org/article/a89ba20876ff4a1bb1595c9d80c83354
Autor:
Bindu Varghese, Lydia Lynch, Lianne E. Vriend, Dobrin Draganov, Justice M. Clark, Haydn T. Kissick, Sharlin Varghese, Martin G. Sanda, Glenn Dranoff, M. Simo Arredouani, Steven P. Balk, Mark A. Exley
Publikováno v:
Varghese, B, Lynch, L, Vriend, L E, Draganov, D, Clark, J M, Kissick, H T, Varghese, S, Sanda, M G, Dranoff, G, Arredouani, M S, Balk, S P & Exley, M A 2022, ' Invariant NKT cell-augmented GM-CSF-secreting tumor vaccine is effective in advanced prostate cancer model ', Cancer Immunology, Immunotherapy, vol. 71, no. 12, pp. 2943-2955 . https://doi.org/10.1007/s00262-022-03210-8
Cancer Immunology, Immunotherapy, 71(12), 2943-2955. Springer Science and Business Media Deutschland GmbH
Cancer Immunology, Immunotherapy, 71(12), 2943-2955. Springer Science and Business Media Deutschland GmbH
Invariant natural killer T cells (iNKT cells) express a semi-invariant T cell receptor that recognizes certain glycolipids (including α-galactosylceramide, αGC) bound to CD1d, and can induce potent antitumor responses. Here, we assessed whether αG
Autor:
Amanda L. Gill, William H. Hudson, Rajesh M. Valanparambil, Eunseon Ahn, Donald J. McGuire, Andreas Wieland, Daniel T. McManus, Haydn T. Kissick, Rama S. Akondy, Rafi Ahmed
Publikováno v:
J Virol
Increased demand for novel, highly effective vaccination strategies necessitates a better understanding of long-lived memory CD8 T cell differentiation. To achieve this understanding, we used the mouse model of acute lymphocytic choriomeningitis viru
Autor:
Yinghong Hu, William H. Hudson, Haydn T. Kissick, Christopher B. Medina, Antonio P. Baptista, Chaoyu Ma, Wei Liao, Ronald N. Germain, Shannon J. Turley, Nu Zhang, Rafi Ahmed
Publikováno v:
JOURNAL OF EXPERIMENTAL MEDICINE
Recent studies have defined a novel population of PD-1(+) TCF-1(+) stem-like CD8 T cells in chronic infections and cancer. These quiescent cells reside in lymphoid tissues, are critical for maintaining the CD8 T cell response under conditions of pers
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::40aad4a44369c4f12d66b28e1e957364
https://biblio.ugent.be/publication/01GZXHYMPXE706WBF3YJ9ZB3MW
https://biblio.ugent.be/publication/01GZXHYMPXE706WBF3YJ9ZB3MW
Autor:
Pragati Sharma, Mohit Singla, Kamalvishnu P. Gottimukkala, Rakesh Lodha, Pushpendra Singh, Sivaram Gunisetty, Sanjeev Kumar, Priya Bhatnagar, Anmol Chandele, Guruprasad R. Medigeshi, Harekrushna Panda, Kaja Murali-Krishna, Yadya M Chawla, Kaustuv Nayak, Charu Aggarwal, Rafi Ahmed, Carl W. Davis, Sushil K. Kabra, Keshav Saini, Elluri Seetharami Reddy, Haydn T. Kissick, Deepti Maheshwari
Publikováno v:
J Virol
Previous studies have shown that plasmablasts expand massively in dengue patients as compared to many other situations such as influenza infection or vaccination. However, a detailed understanding of the phenotypes and transcriptional features of the
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)
BackgroundCD4 T cells can differentiate into multiple effector subsets that can mediate variable functions. In this work we aim to understand how CD4 T cells differentiate in response to tumor antigens and their respective function in the anti-tumor
Autor:
Haydn T. Kissick, Maria Cardenas, Jennifer W Carlisle, Adeboye O. Osunkoya, Caroline S. Jansen, Viraj A. Master, Patrick Mullane, Mehmet Asim Bilen, Rachel Greenwald, Ewelina Sobierajska, Nataliya Prokhnevska
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)
BackgroundTumor infiltrating T-cells have a prognostic benefit in many tumor types,1–8 and we recently sought to determine whether the level of T-cell infiltration into renal tumors predicts clinical outcomes. In our recent publication,9 we showed
Autor:
Edmund K. Waller, Maria Cardenas, Gregory B. Lesinski, Bassel F. El-Rayes, Jingru Zhu, Mohammad Y. Zaidi, Shuhua Wang, Brian S. Robinson, Michael B. Ware, Susan N. Thomas, Yuan Liu, Tenzin Passang Fnu, Shanmuganathan Chandrakasan, Sruthi Ravindranathan, Jian-Ming Li, Alan B. Frey, Rohan K. Dhamsania, Sanjeev Gumber, Anish Majumdar, Haydn T. Kissick
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)
BackgroundPaucity of T cells in the immune privileged tumor microenvironment (TME) of pancreatic ductal adenocarcinoma (PDAC) is a major reason that PDAC is refractory to immune checkpoint blockade.1 In this study, we show that human PDAC tumors over
Autor:
Haydn T. Kissick, Maria A. Cardenas, Martin G. Sanda, Viraj A. Master, Nataliya Prokhnevska, Rajesh M. Valanparambil, Ewelina Sobierajska, Caroline S. Jansen
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)
BackgroundCD8 T cell are a crucial part of the immune response to tumors, with CD8 infiltration predicting disease progression in numerous cancer types. Recently two subsets of CD8 T cells that respond to tumors have been described, a stem-like (TCF1
Autor:
Wayne Harris, Bradley C. Carthon, Shreyas S. Joshi, Julie M. Shabto, Deepak Ravindranathan, Jacqueline T. Brown, Omer Kucuk, Sarah Caulfield, Kenneth Ogan, Dylan J. Martini, Viraj A. Master, Haydn T. Kissick, Lauren Yantorni, Emilie Elise Hitron, Mehmet Asim Bilen, Yuan Liu, Greta Russler, Bassel Nazha
Publikováno v:
Journal for Immunotherapy of Cancer
Journal for ImmunoTherapy of Cancer, Vol 9, Iss 7 (2021)
Journal for ImmunoTherapy of Cancer, Vol 9, Iss 7 (2021)
BackgroundThe modified Glasgow Prognostic Score (mGPS) is a composite biomarker that uses albumin and C reactive protein (CRP). There are multiple immune checkpoint inhibitor (ICI)-based combinations approved for metastatic renal cell carcinoma (mRCC